Best of ASCO 2024 Annual Meeting in Qatar Discusses Latest Research and Treatment Practices

Doha: Hosted by Hamad Medical Corporation (HMC) in partnership with the Qatar Cancer Society (QCS), the Best of the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting brought together leading cancer professionals to discuss the latest research and treatment practices. The Annual Meeting was an occasion for 300 healthcare professionals, academics, students, and industry representatives to explore advancements in emerging therapeutics, including immunotherapy, molecular precision medicine, tumor biology, and new symptom management and survivorship approaches. Focusing on "Shaping Cancer Care Together," the conference provided a platform for participants to explore various topics, including the management of common cancers such as breast, colon, lung, and prostate, as well as rare conditions like neurological, head and neck, urological, gynecological cancers, and sarcomas. Commenting on the event, Deputy Medical Director for Education, Research, and Quality at the National Center for Cancer Care and Research and Chairman of the Best of ASCO 2024 in Qatar Dr. Mohammed Ussama Al Homsi said, "The Best of ASCO 2024 has once again proven to be an invaluable prospect for healthcare professionals to engage with the latest global research and treatment practices. This event has reinforced our commitment to advancing cancer care in Qatar." Dr. Al Homsi added, "This conference has successfully facilitated the exchange of cutting-edge knowledge, enhancing our collective understanding of cancer care. By addressing both prevalent and rare cancers, we are making significant strides in improving patient outcomes and advancing the field." In turn, Director of the Pharmacy Department at the National Center for Cancer Care and Research and Chairman of the Organizing Committee for Best of ASCO 2024 in Qatar Dr. Anas Hamad emphasized the significance of collaboration and teamwork: "We had 41 lectures in the scientific program provided by regional and local experts, and 38 scientific posters presented by cancer researche rs in Qatar, which covered several topics related to practice and science. Dr. Hamad also highlighted the role of innovation in the event: "The conference underscored our commitment to integrating innovative research into clinical practice. Our focus on emerging therapies and precision medicine ensures that Qatar remains at the forefront of cancer care, offering our patients the most effective treatments available." Source: Qatar News Agency